, lactate production and oxidation, and glucose oxidation from carbon 1-and carbon 6-labeled substrates, it was determined that (a) mitogens such as phytohemagglutinin enhance basal T lymphocyte intermediary metabolism, (b) physiologic concentrations ofinsulin have no impact on the metabolism of unstimulated, cultured, receptornegative lymphocytes, and (c) insulin provided to receptor bearing lymphocytes augments intermediary metabolism above mitogen stimulated levels. The importance of the pentose phosphate shunt pathway for energy metabolism in the stimulated lymphocyte was confirmed. These studies demonstrate that insulin has a classical physiologic role to play in the activated lymphocyte further validating the use of this cell to examine potential receptor defects in disorders of carbohydrate metabolism. By enhancing energy metabolism of stimulated lymphocytes, insulin serves biologic economy and thus may perform its immunoregulatory role.
INTRODUCTION
Insulin conveys its metabolic message to cells by means of a binding reaction to a membrane bound receptol protein. Determination Received for publication 27 June 1980 and in revised form 26 January 1981.
1636
tend animal studies to man, it was desirable to discover receptor sites on cells that could be conveniently, repetitively, and safely obtained. Indeed, in a series of elegant studies, such receptor sites were characterized upon circulating cells that could then serve as "mirrors of cellular metabolism" (1) (2) (3) (4) . Initially, pains were taken to demonstrate that characteristics of insulin receptors on these circulating cells -were identical to those existent for more traditional targets of the hormone. Additionally, circulating cells exhibited similar deviations from normal during experimental and pathophysiologic perturbation as that observed for target tissues. Nevertheless, the failure to readily measure a metabolic role for the hormone in these circulating cells has called the use of the circulating cell as a model of receptor alterations during disease into question. The resting lymphocyte, a circulating cell that has been used as such a model, does not bear insulin receptors in vivo (5) . One should not perforce expect insulin to exert classical metabolic effects upon these resting, receptor-negative cells. This study was designed to validate the use of the activated lymphocyte model for the exploration of the pathogenesis of disorders of carbohydrate metabolism. It explores the hypothesis that insulin has a true biologic role in the lymphocyte which is revealed during cellular activation when an insulin receptor appears upon the membrane and is available for binding.
METHODS
Cell preparation. Lewis male rat spleens were teased through a sterile steel mesh into RPMI-1640 tisstue culltuire mediulm (Microbiological Associates, Walkersville, Md.) buiffered with 10 mM Hepes and fortified with 5% (vol/vol) sterile, heat-inactivated, instl in-depleted (<1. 5 ,uU/mil) fetal call serum. Mononuclear leukocytes were collected from the interface of a Ficoll-Hypaque density gradient (specific gravity, 1 .091) and washed twice. T lymphocytes were obtained by passing these leukocytes over nylon wool columns prepared by the method of Handwerger and Schwartz (6) as described (5) . Such cells were >95% T pedigree as deter-mined by cell markers performed as described in part by Soulillou et al. (7) and by Helderman and Strom (5) .
Cellular activation. Induction of insulin receptors was accomplished by activation of the T lymphocytes by co-culturing the cells with the mitogen phytohemagglutinin P (PHAp),1 100 /ig/ml (Difco Laboratories, Detroit, Mich.) (8) (9) . Cultures were established in RPMI-1640 media buffered with 10 mM Hepes and enriched with insulin-poor fetal calf serum for 48 h at 37°C in an atmosphere of 5% CO2 and air. At the completion of the culture, the cells were harvested, washed, and analyzed for both insulin receptor binding and for the specific metabolic function under consideration.
Insulin binding assay. The basic assay technique, a modification of that described by Gammeltoft and Gliemann (10, 11), has been extensively described in a previous publication (5) and validated further in others (9, 12) . The modification permits sedimentation of lymphocytes through phthalate oils at a density at which 97% of the lymphocytes are recovered in the pellet, whereas contamination of the pellet by free ligand is only 0.04% (12) 33 and 50% of the total in binding curves using physiologic concentrations of insulin. In the present studies an aliquot of lectin-treated, nylon woolfiltered, T-enriched cells were reserved for measurement of receptors to insure that the PHA exerted its usual and expected effect as a stimuluis for lymphocyte insulin receptor generation. ['251 ]iodoinsulin binding to PHA-treated T lymphocytes was determined at 2 ng/ml (on the rapid portion of the association binding isotherm for this cell [5] ) in the presence and absence of 4 /Lg/ml unlabeled insulin.
3-O-CH3 glucose transport. After the binding assay confirmed the presence of insulin receptors on PHA-treated cells and the absence of receptors on untreated, cultured cells (negative controls), the cell density was adjusted to 25 x 10li/ ml in a buffered salt solution containing 90 mM NaCl, 8 mM KCI, 0.4 mM CaCl2 6H20, 0.4 mM MgSO4 7H2O, 50 mM 3-(N-morpholino) propane-sulfonic acid (CalbiochemBehring Corp., American Hoechst Corp., La Jolla, Calif.), 2 mM NaH2PO4, pH 7.4. To determine the temporal relationships that govern transport, 100 ,ul of the cultured cells at that concentration was placed into 12 x 75-mm glass tube containing 15 ,ul of the buffer and 50 Al of 3-O-[methyl-3H]-D-glucose (90 mCi/mmol; New England Nuclear, Boston, Mass.) at a final concentration of 0.1 mM. The reaction was allowed to proceed at 370C in a shaking water bath and stopped at various times by placing 150 ,ul of the reaction mixture on a bed of phthalate oils in plastic microfuge tubes (10:1 ratio of dibutyl to dinonyl), then centrifuging at 10,000 rpm in a Beckman microfuge (Beckman Instruments, Inc., Fullerton, Calif.). The cell button was reserved by cutting the tip of the microfuge tube into a scintillation phial containing 3 ml of fluor (500 ml Triton X-100 in 15 liters of toluene containing PPO 10.5 g and POPOP 0.15 g). This separation method allowed recovery of >98% of the cells initially placed atop the oil with <0.01% contamination of the oil by free isotope determined as described (12 Aminoisobutyric acid tr(ainsport. Cells prepared and treated with lectin as above were placed at 12.5 x 106 lymphocytes/ml in Hanks' balanced salt solution (Microbiological Associates) -0.1% bovine serum albumin. 160 ,ul of the cell mixture was placed in 12 x 75-mm glass test tubes to which 20 ,ul media or inisulin was added (final concentration 1 nNI) and incuibated at 37°C in a shaking water bath for 10 min, a time determined in pilot experiments to provide maximal insulin effect. 20 ,l a-[1-'4C] aminoisobutyric acid (AIB), (51.6 mCi/ mmol) (New England Nuclear) was added to make a final concentration of 95 ,uM. The tubes were then incubated further for times varying over 75 min. The transport reaction was stopped by the addition of 2 ml of ice cold Hanks' balanced salt solution followed by a 2-min spin at 2,000 rpm at 4°C in the Sorvall centrifuge. The cells were washed twice in ice-cold media and the intracellular AIB was obtained by hypotonic (0.5 ml water) and freeze-thaw lysis of the final cell pellet. Cell debris was renmoved by another 2,000 rpm spin at 4°C. The superniate was decaanted into 10 ml of fluor (40 ml Permafluor I, Packard Instrument Co., Downers Grove, Ill.; 1 liter toluiene; and 100 ml BioSolv, Beckman Instruments Inc.) and counted in a liquid spectrophotometer.
RESULTS
Insulin binding. Cells for the various metabolic studies were used only when the expected lectin-induced insulin receptor generation was observed. Using 2 ng/ml [251ljiodoinsulin as ligand, 3.21±0.13 pg (mean + SEM) were specifically bound to 106 T cells after 48 h incubation with PHA (100 ug/ml), binding comparable to that observed in our studies that first characterized the effects of this lectin with respect to the T lymphocyte insulin receptor (8, 9) . The untreated cells had 0.07 +0.03 pg/106 bound, well below the detectable positive binding limit obtained in our assay (-0.8 pg/ 106). These data demonstrated that lectin-treated T cells were insulin receptor-bearing cells and that untreated, cultured cells were receptor-negative, thus serving as controls.
3-0-methyl glucose transport. Time-course experiments (n = 4, Fig. 1 ) demonstrated that uptake equilibrium was reached between 10 and 15 min after presentation of the labeled 3-0-methyl glucose to the cells. PHA-stimulated, receptor-bearing T cells had a greater flux than was present in the basal culture untreated with lectin, as indicated by the comparison of the slopes of the uptake in Fig. 1 insulin-directed increase in these control cells the change was small (0.027+0.007 nmol/106 h with no preincubation with insulin as compared to 0.061+0.018 at 0.1 nM insulin) and not significant. In marked contrast was the insulin effect on receptor-positive T cells ( Fig. 2A) . In these studies, a dose-directed augmentation of glucose oxidation was observed with a maximal oxidation rate of 0.233+0.027 nmol/l106 h. Similar relationships between lectin activation and insulin augmentation were observed when T lymphocytes were provided substrate labeled on the first carbon of the glucose skeleton (Fig. 2B) . For these studies, mitogen treatment stimulated basal oxidation rates from 0.60+0.10 to 1.19±0.15 nmol/106 h (n = 5; P < 0.01); insulin exerted no enhancing effect for oxidation in insulin receptor-negative cells, while strongly increasing oxidation in receptor-bearing T cells. Note that CO2 formation from the carbon 1-labeled substrate is an order of magnitude greater than that observed from D-6-'4C, an observation similar to that of MacLennan and Golstein (13) .
Lactate production and oxidation. Insulin supported lactate production was examined in six experiments performed in cells with and without the insulin receptor (Fig. 3) ring the oxidation of test), but the magnitude of the increase in transport was small. Enhancement to nearly 25% at 1 nM insulin was similar to that observed by Goldfine (16) (21) (22) (23) (24) and confirm the well described effects of PHA (23, 25, 26) . The role of insulin on glucose transport in receptor negative cells was explored by Hadden and co-workers (27) who reported an augmentation only when pharmalogic doses were used over time. That physiologic concentrations (100 ,uU/ml for 4 h) failed to enhance transport supports the conclusion that insulin exerts this classical biologic function only on receptor-bearing T cells. The failure to observe an insulin effect on glucose use in freshly prepared lymphoid tissues is consonant with the bulk of previous work (17, 19, 20, 28, 29) although Hofert In contrast to the instulin-directed alterations in the rate of intermediary metabolism of the T cell that have been defined and discussed to this point was the failure to identify insulin effects on lactate concentrations.
Lymphocyte lactate concentrations were markedly increased by cellular activation alone so that maximal levels might already have been achieved. On the other hand, the measurement of static lactate levels is a balance of synthesis, degradation, and oxidation to pyruvate. Therefore the effect of insulin on net lactate oxidation to CO2 was examined. The augmentation of CO2 formation from the lactate substrate induced by insulin in the activated cell may provide a partial explanation for the stable albeit elevated lactate levels with the addition of hormone to receptor-bearing cells. Insulin could have increased lactate formation directly (or indirectly through provision of increased substrate); enhancement of oxidation of lactate might have balanced the increased rate of formation so that no net change above lectin activated formation rates was observed.
Finally, I would like to discuss possible immunologic consequences that might flow from the demonstration that insulin exhibits an important role for lymphocyte intermediary metabolism only when an insulin receptor is present on an activated cell. Recently it has become clear that insulin participates in hormonal immunoregulation (5, 34) . The T lymphocyte can become an immune effector, a cytotoxic lymphocyte, or an accessory cell in grading direct responses of other T cells or B cells. During this process the cell attains an insulin receptor that permits, only when present, insulin to alter at least the cytotoxic responses of that cell (9, 35) . These studies expand the understanding of potential mechanisms whereby insulin serves as an immuinoregulator in that these activated receptor-bearing T cells are poised to permit ambient insulin concentrations to augmenit intermediary metabolism to meet the energy demands of the responding lymphocyte to stimulus. Although insulin may not be an absolute requirement for T cell effector of function, these studies demonstrate the manner in which insulin plays a classical physiological role in the activated, responsive, receptor-bearing T lymphocyte that permits the hormone to serve biologic economy.
